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Abstract
The canonical Wnt/b-catenin pathway plays a key role in the regulation of bone remodeling in mice and humans. Two
transmembrane proteins that are involved in decreasing the activity of this pathway by binding to extracellular antagonists,
such as Dickkopf 1 (Dkk1), are the low-density lipoprotein receptor related protein 5 (Lrp5) and Kremen 2 (Krm2). Lrp 5
deficiency (Lrp52/2) as well as osteoblast-specific overexpression of Krm2 in mice (Col1a1-Krm2) result in severe
osteoporosis occurring at young age. In this study, we analyzed the influence of Lrp5 deficiency and osteoblast-specific
overexpression of Krm2 on fracture healing in mice using flexible and semi-rigid fracture fixation. We demonstrated that
fracture healing was highly impaired in both mouse genotypes, but that impairment was more severe in Col1a1-Krm2 than
in Lrp52/2 mice and particularly evident in mice in which the more flexible fixation was used. Bone formation was more
reduced in Col1a1-Krm2 than in Lrp52/2 mice, whereas osteoclast number was similarly increased in both genotypes in
comparison with wild-type mice. Using microarray analysis we identified reduced expression of genes mainly involved in
osteogenesis that seemed to be responsible for the observed stronger impairment of healing in Col1a1-Krm2 mice. In line
with these findings, we detected decreased expression of sphingomyelin phosphodiesterase 3 (Smpd3) and less active b-
catenin in the calli of Col1a1-Krm2 mice. Since Krm2 seems to play a significant role in regulating bone formation during
fracture healing, antagonizing KRM2 might be a therapeutic option to improve fracture healing under compromised
conditions, such as osteoporosis.
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Introduction
The canonical Wnt/b-catenin pathway has been intensively
investigated over the past decade because of its key role in the
regulation of skeletal development and bone mass maintenance
[1]. The remarkable finding that loss-of-function mutations in the
Wnt coreceptor low-density lipoprotein receptor related protein 5
(LRP5) gene cause the osteoporosis-pseudoglioma syndrome
(OPPG), a rare autosomal recessive disorder of severe juvenile
osteoporosis and congenital blindness, and that gain-of-function
mutations in this gene result in a high bone mass phenotype,
provided first evidence for the considerable influence of Lrp5
signaling on bone remodeling [2,3]. In addition, studies using
transgenic mouse models are currently reflecting the high impact
of Wnt signaling on bone mass regulation [4–6]. Thus, targeted
disruption of Lrp5 in mice results in a low bone mass phenotype
due to decreased osteoblast proliferation and function [7]. The
osteoporotic phenotype and persistent eye vascularization recapit-
ulates the human OPPG syndrome. Although most of the
transgenic animal models that affect bone mass specifically target
canonical Wnt signaling, there is increasing evidence that
noncanonical Wnt signaling pathways, the Wnt-planar cell
polarity (Wnt-PCP) and the Wnt-calcium (Ca2+) pathway, play
a significant role in bone mass homeostasis. Thus, it has been
demonstrated that there may be a crosstalk between these
pathways and that some Wnts are able to activate more than
one of these pathways in a receptor-dependent manner. [1,5].
There is evidence that canonical Wnt signaling needs to be
downregulated in mature osteoblasts to enable bone matrix
mineralization [8]. Therefore, extracellular antagonists, including
Dickkopf 1 (Dkk1), a member of a small family of secreted
proteins, are upregulated during osteoblast differentiation [6,8].
Dkk1 binds to both coreceptors, Lrp5/6 and with high affinity to
the transmembrane proteins Kremen 1 or 2 (Krm1, Krm2),
thereby forming a ternary complex that undergoes rapid
endocytosis and removal of the Lrp coreceptors from the cell
membrane, resulting in an inhibition of Wnt/b-catenin signaling
[9]. Deleting both, Krm1 and additionally Krm2 expression in
mice leads to an increase of bone volume, which was comparable
to that observed in haploinsufficient Dkk1 (+/2) mice [10].
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Osteoblast-specific overexpression of Krm2 in transgenic mice
(Col1a1-Krm2) results in severe osteoporosis that is associated with
an impaired osteoblast maturation and bone formation as well as
increased bone resorption [6]. Consequently, these data demon-
strate that Krm2, at least in mice, is an important regulator of
bone remodeling by inhibiting bone formation while increasing
bone resorption.
Various studies have already shown the crucial role of Wnt/b-
catenin signaling in bone fracture repair [11]. Canonical Wnt
signaling has been shown to be important in the early phase of
fracture repair to allow differentiation of mesenchymal cells into
either chondrocyte or osteoblast lineages [12]. b-Catenin mediated
Tcf-dependent transcription is activated during both, chondro-
genesis as well as osteogenesis in fracture healing and is
downregulated in the later phase of osteogenesis, as osteoblasts
mature to osteocytes. Using various transgenic mouse models it
has been demonstrated that a precisely stage-specifically regulated
canonical Wnt signaling is necessary in order to allow complete
fracture healing [13]. Fracture healing was impaired in mice
conditionally expressing b-catenin null alleles. These mice had a
lack of bone and cartilage and showed immature mesenchymal
cells at the fracture site. Fracture healing was also repressed in
mice expressing the null allele specifically in osteoblasts. These
observations are in line with previous studies demonstrating that
activated canonical Wnt signaling can interfere with the differen-
tiation of skeletal precursors into chondrocytes and osteoblasts
[14,15]. Canonical Wnt signaling has been shown to maintain
mesenchymal stem cells in a less differentiated state during
osteogenic differentiation. In contrast, in cells already committed
to the osteoblast phenotype, activated b-catenin signaling
promotes osteoblastic differentiation and enhances osteogenesis,
whereas in osteoblast precursors lacking b-catenin osteoblast
differentiation is inhibited and they develop into chondrocytes
[16,17].
It has been shown that suppression of Wnt pathway inhibitors
[18] and activation of b-catenin signaling can enhance healing,
whereas b-catenin pathway inhibitors can delay bone regeneration
[19]. Based on all these findings, it is obvious that Wnt/b-catenin
signaling activation during a defined time during fracture healing
might be an excellent option for the improvement of fracture
healing under compromised conditions, such as osteoporosis.
However, clarifying the role of signaling molecules regulating this
pathway in fracture healing is a prerequisite to expand the small
number of anabolic drugs that are currently available and
evaluated for bone regeneration.
Apart from molecular factors, the mechanical environment that
is determined by the fixation stability has an important influence
on the fracture healing outcome [20]. Thus, more rigid fracture
stabilization promotes intramembraneous ossification, whereas
more flexible fracture fixation increases endochondral bone
formation. Previously, we established standardized models for
investigating the impact of mechanical factors on bone healing in
mice, allowing for the adjustment of flexible and semi-rigid
conditions [21].
In the present study we examined the influence of Lrp5
deficiency and osteoblast-specific Krm2 overexpression on fracture
healing in mice with flexible and semi-rigid fixation, respectively.
Both mouse models are known to be associated with an
osteoporotic phenotype due to impaired Wnt signaling. We
hypothesized that these mouse models show a genotype-specific
delayed healing compared to wild-type mice that is more evident
in mice with the more flexible fracture fixation compared to mice
with the semi-rigid fracture fixation.
Material and Methods
Animals
The experiments were performed according to international
regulations for care and use of laboratory animals, and approved
by the local ethical committee (Regierungspra¨sidium Tu¨bingen,
No. 906, Germany). Col1a1-Krm2 transgenic mice (C57BL/6
genetic background) were generated as previously described [6]. In
brief, the ORF encoding the Dkk receptor Krm2 was placed under
the control of an osteoblast-specific Col1a1 promoter fragment.
Schulze et al. performed RT-PCR to confirm the bone-specific
expression of the transgene, and using Northern blot analysis with
RNA isolated from the femura of the transgenic animals they
found that the expression was at lest 20-fold increased compared
to the expression in the bone of wildtype animals [6]. Lrp5-
deficient mice (Lrp52/2) mice (C57BL/6 genetic background)
were provided by Jackson Laboratory (005823, Bar Harbor,
Maine, USA). Mice were kept in individual cages with a 12 h
circadian rhythm and were given ad libitum access to food and
water.
Fracture healing study
Female, 26 weeks old mice (n = 78) of each genotype (n = 22–30,
2563 g body weight) were used for the study. For investigation of
fracture healing at day 21 the mice were randomly divided into
three groups (C57BL/6 wildtype, Lrp52/2 and Col1a1-Krm2
mice) with either semi-rigid (n = 7–11/group) or flexible fracture
fixation (n= 4–7/group) in order to generate mechanical condi-
tions inducing regular or delayed healing, respectively [21].
Motion and ground reaction forces were monitored during the
healing period in order to control proper limb loading [21]. 21
days after surgery the mice were euthanized by carbon dioxide
inhalation. The fracture calli of each genotype with either semi-
rigid (n = 7–11) or flexible fracture fixation (n = 4–7) were
evaluated at day 21 by biomechanical and histological evaluation
and by micro-computed tomography (mCT). Additional animals of
each genotype with semi-rigidly fixated osteotomy were sacrificed
10 days after surgery for a genome-wide comparative gene
expression analysis of the fracture callus (n = 5–6) and for
histological and immunohistological (n = 5–6) evaluation.
Surgical procedure
All animals received an analgesic (15 mg/kg, Tramal, Grue-
nenthal GmbH, Aachen, Germany) subcutaneously during the
operation and in the drinking water (25 mg/l) for the first 3
postoperative days. After a subcutaneous injection of atropine
sulfate (50 mg/kg, Atropin, Braun, Melsungen, Germany) the mice
were anesthetized with 2% isoflurane (Forene, Abbott, Wiesbaden,
Germany). For antibiosis the animals received daily subcutaneous
injections of clindamycin-2-dihydrogenphosphate (45 mg/kg,
Clindamycin, Ratiopharm, Germany) until the 3rd postoperative
day. Penetrating the fascia lata between the gluteus superficialis
and biceps femoris muscles the femur was exposed. The fixator
was fitted in a cranio-lateral position using 4 mini-Schanz screws
(Research Implant System, RIS, Davos, Switzerland), placing the
1st and 2nd screw proximal and distal of the trochanter tertius,
respectively. In order to provoke regular or delayed bone healing a
semi-rigid (axial stiffness 18.1 N/mm) or flexible (axial stiffness
0.82 N/mm) fixator was used [21]. A standardized osteotomy gap
of 0.5 mm was created at the mid-shaft of the right femur in the
middle between the inner screws by using a 0.45 mm Gigli saw.
The muscles were sutured with absorbable (Vicryl, J&J, Norder-
stedt, Germany), and the skin with nonabsorbable thread
(Resolon, Resorba, Nuernberg, Germany). All mice were allowed
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to move freely immediately post-surgery. Mice were sacrificed 10
or 21 days postoperatively using carbon dioxide inhalation.
Biomechanical testing
In order to determine the mechanical properties of the fracture
callus the bending stiffness was analyzed by a non-destructive 3-
point bending test after a healing period of 21 days as described
before [21]. Briefly, the proximal end of the femur was fixed in an
aluminum cylinder with SelfCem (Heraeus Kulzer, Hanau,
Germany). The cylinder itself was fixed in a hinge joint, serving
as the proximal support for the bending test. The femoral condyles
rested on the bending support, the distance between both supports
being 20 mm (l). The bending load F was applied on the midshaft
and continuously recorded versus sample deflection (d) up to a
maximum force of 5 N. Since the callus was not always located in
the middle of the supports (l/2), the distances between the load
vector and the proximal (a) and distal (b) supports were considered
for calculating the bending stiffness EI = k((a2b2)/3 l) [21].
mCT scanning
At day 21 post fracture the femora were imaged at a resolution
of 30 mm, using a mCT Fan Beam Yscope System (Stratec
Medizintechnik GmbH, Pforzheim, Germany) operating at a peak
voltage of 40 kV and 140 mA. 3D reconstructions were visualized
using 3D software (VG Studio Max 1.0; Volume Graphics,
Heidelberg, Germany) and total volume (TV), maximum moment
of inertia (Imax), and bone volume fraction (BV/TV) were
measured after segmentation of the former osteotomy gap. Global
thresholding was performed to distinguish between mineralized
and non-mineralized tissue. The gray value corresponding to 25%
of x-ray attenuation of the cortical bone of each specimen was
taken as threshold [21].
Histology
The fracture calli harvested 21 days after surgery were
processed for undecalcified histology. The bones were fixed in
4% formaldehyde, dehydrated by increasing ethanol concentra-
tions and embedded in methyl methacrylate. 70 mm sections were
cut and surface stained with Paragon (Paragon C&C, New York,
NY). The newly formed callus was examined qualitatively and
quantitatively under light microscopy (Axiophot; Zeiss, Oberko-
chen, Germany). The relative amounts of bone, cartilage, and soft
tissue were determined at the osteotomy gap by the point counting
method. Additionally, bony bridging of the fracture gap was
evaluated in the histological slides at 4 positions at the fracture
gap: anterior and posterior callus each peripherally (periosteal
callus) and in between the cortices (intracortical callus). To
describe the quality of bony bridging we used a scoring system
(4 = complete bony bridging at all 4 locations; 3 = at 3 locations;
2 = at 2 locations; 1 = at 1 location; 0 = no bony bridging).
Additional fracture calli were harvested 10 days after surgery
from rigidly fixated groups and processed for decalcified histology.
The specimens were fixed in 4% formaldehyde, decalcified in 20%
EDTA and embedded in paraffin. Longitudinal sections of 5–
7 mm were stained by Giemsa (Merck, Darmstadt, Germany) and
the relative amounts of osseous tissue, cartilage, and fibrous tissue
were determined as described above.
Immunohistochemistry
Osteoclasts were identified by histochemical staining of tartrat-
resistant acid phosphatase (TRAP) (Leucocyte Acid Phosphatase
Kit, Sigma Aldrich Chemie GmbH, Steinheim, Germany) and
counted in the whole peripheral callus. Additional paraffin sections
were used for immunostaining of sphingomyelin phosphodiester-
ase 3 (Smpd3) by the use of a polyclonal anti-mouse Smpd3
antibody (Santa Cruz Biotechnology Inc., Heidelberg, Germany).
To detect the primary antibody, labeled-streptavidin-biotin
method (LAB-SA, Histostain-Plus Kit, Life Technologies GmbH,
Darmstadt, Germany) was used and 3-amino-9-ethylcarbazole
(AEC) was used as chromogen (Zytomed Systems, Berlin,
Germany). The monoclonal non-phospho (active) b-catenin
antibody (Cell Signaling, Danvers, MA, USA) and the polyclonal
anti-collagen type II antibody (Rockland, Gilbertsville, PA, USA)
were used together with the Vectastain ABC kit (Vector
Laboratories, Burlingham, CA, USA) to detect the stabilized
active form of endogenous b-catenin and collagen type II,
respectively. Finally, counterstaining with hematoxylin (Waldeck,
Mu¨nster, Germany) was performed. The sections were qualita-
tively evaluated under light microscopy.
Whole transcriptome analysis of the fracture callus
Three mice of each wildtype, Lrp52/2 and Col1a1-Krm2 with
semi-rigidly fixated osteotomy were sacrificed 10 days after
operation. Whole femur was dissected and immediately shock
frozen in liquid nitrogen. Callus region (in the following referred to
as callus) between 2nd and 3rd pin hole was homogenized using a
knife-rotor homogenizator (T 10 basic ULTRA-TURRAX, IKA-
Werke GmbH & Co. KG, Staufen, Germany). Total RNA was
isolated with RNeasy Lipid Tissue Mini Kit (Qiagen, Hilden,
Germany) according to manufacturer’s instructions. Following
amplification, labeling and fragmentation according to the Gene
Chip 39IVT Express Kit (Affymetrix, High Wycombe, United
Kingdom), 10 mg of cRNA were hybridized on Affymetrix Gene
Chips Mouse Genome 430 2.0. Hybridization signals were
detected by Affymetrix Gene Chip Scanner 3000 and global
normalization was performed by Affymetrix Gene Chip Operating
Software 1.4 using the MAS5 algorithm. Normalized data of three
calli of wildtype mice were crosswise compared to three calli of
Lrp52/2 mice and Col1a1-Krm2 mice, respectively. Statistical
analysis was performed by Partek Genomic Suite (Partek
Incorporated, St. Louis, USA) using ANOVA test with multiple
testing corrections. The complete data were deposited in NCBI’s
Gene Expression Omnibus (GEO, http://www.ncbi.nlm.nih.gov/
geo/) and are accessible through GEO SuperSeries accession
number GSE51686. Differential gene expression in the compar-
isons Lrp52/2 versus wildtype and Col1a1-Krm2 versus wildtype
was regarded as significantly reliable when gene products (probe
sets) fulfilled the following criteria: present calls in all three samples
of at least one of the compared groups; change p-value ,0.002 for
the increased expression and p-value .0.998 for the decreased
expression in at least 7 of the 9 cross-comparisons. Categorization
of genes into functional groups was done by using Gene Ontology
(GO) classification. (http://www.geneontology.org/).
Quantitative real-time PCR
For cDNA synthesis we used 1 mg of total RNA of fracture calli
harvested from wildtype mice (n = 6), Lrp52/2 mice (n= 6) and
Col1a1-Krm2 mice (n= 5) including the 3 RNA samples of
microarray hybridization. Reverse transcription was performed
with Oligo(dT)15 primers (Peqlab Biotechnologie GmbH, Erlan-
gen, Germany) using MMLV reverse transcriptase (Promega
GmbH, Mannheim, Germany) according to the manufacturer’s
instructions. Quantitative real-time PCR (qPCR) was performed
using KAPA SYBR FAST Universal 2xqPCR Master Mix (Peqlab
Biotechnologie GmbH) and 0.25pmol of sequence specific primers
obtained from biomers.net GmbH (Ulm, Germany) (Table 1).
Results were calculated with the efficiency-corrected Ct model
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[22] with B2m as the house-keeping gene. Groups were compared
with non-parametrical Mann-Whitney U test.
Statistics
The statistical methods used for analysis of the microarrays and
qPCR were already described in the corresponding paragraphs
above. Results are presented as mean and standard deviation (SD).
The number of animals included in the different groups (three
genotypes with either flexible or more rigid fixation) is indicated in
the legends. Biomechanical, mCT, and histochemical data of the
groups were compared with non-parametrical Mann-Whitney U
test using PASW Statistics 18.0 software (SPSS Inc., Chicago,
USA). Level of significance was p#0.05.
Results
Alterations in fracture healing do not result from
differing limb loading
In order to exclude that alterations in bone healing result from
differing mechanical stimuli acting on the regenerating tissue we
recorded the ground reaction forces of the operated limb and the
activity of the Lrp52/2 and Col1a1-Krm2 mice. The activity of the
animals decreased postoperatively to about 70% of the preoper-
ative value and then tended to increase to preoperative values with
regard to wildtype mice (Fig. 1A). On average, the activities of
Lrp52/2 and Col1a1-Krm2 mice did not seem to reach these
values. However, there were no significant differences between the
three genotypes. The ground reaction forces of the operated limb
postoperatively declined by about 20% and remained at this level
during the entire healing period (Fig. 1B). We could not detect any
significant differences between the genotypes. It can therefore be
suggested that the osteoporotic mice loaded the operated limb
properly, ensuring that alterations in bone healing are caused by
the genotype and not by differing mechanical conditions in the
fracture gap.
Krm2 overexpression in osteoblasts and Lrp5 deficiency
impair regular fracture healing
To investigate fracture healing under better mechanical
conditions we used a semi-rigid fixator, which has previously
been shown to allow fast bone healing by promoting intramem-
branous with respect to endochondral bone formation [21]. As one
important parameter for successful fracture healing we assessed the
mechanical competence of both, the healed femurs at day 21 post
fracture, the time point of bony bridging of the gap, as well as of
the contralateral intact femurs. The stiffness of the intact Lrp52/2
and Col1a1-Krm2 femurs was significantly decreased compared to
the wildtype confirming their osteoporotic phenotype [6,7]
(Fig. 2A). The stiffness of the healed femurs was considerably
reduced, by 50% in Lrp52/2-deficient mice and by 58% in
Col1a1-Krm2 transgenic mice compared to wildtype controls
(Fig. 2A). By comparing the stiffness of the osteotomized to the
intact femurs we found that healed bones did not reach the
mechanical competence of the intact bones in all mice strains at
this time point of evaluation. The relative stiffness was most
decreased in Col1a1-Krm2 mice (Fig. 2A). These data were
confirmed by the semiquantitative assessment of bony bridging of
the osteotomy gaps. Whereas most of the wildtype mice exhibited
Table 1. Quantitative PCR primer sequences.
Gene name Forward primer (59-39) Reverse primer (59-39) NCBI Accession No.
Alpl aacccagacacaagcattcc gagagcgaagggtcagtcag NM_007431.2
B2m gtctttctggtgcttgtctc agttcagtatgttcggcttc NM_009735.3
Col1a1 ggcaagaatggagatgatgg accatccaaaccactgaagc NM_007742.3
Cyclin D1 ttgactgccgagaagttgtg ctggcattttggagaggaag NM_007631.2
Cyclin E1 acagcttggatttgctggac actgtctttggaggcaatgg NM_007633.2
Pth1r accccgagtctaaagagaac taaatgtaatcgggacaagg NM_001083936.1
Tnfrsf11b tgttccggaaacagagaagc actctcggcattcactttgg NM_008764.3
doi:10.1371/journal.pone.0103250.t001
Figure 1. The different genotypes do not affect limb loading during fracture healing. (A) Motion of the mice was measured pre- and
postoperatively using an infrared beam detection system. (B) Peak vertical ground reaction forces of the operated limb were recorded during
movement of the mice using a force plate. n = 3–7 randomly selected mice per group (wildtype: dashed line (n = 7), Lrp52/2: without line (n = 3),
Col1a1-Krm2: black line (n = 6)). Postoperative values were related to preoperative measurements. Data are expressed as means 6 SD.
doi:10.1371/journal.pone.0103250.g001
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Figure 2. Krm2 overexpression in osteoblasts and Lrp5 deficiency impair regular fracture healing. The fractured femurs of wildtype,
Col1a1-Krm2 and Lrp52/2 mice were stabilized using a semi-rigid fixator in order to provide better mechanical healing conditions as described in the
Material and Methods section. (A) In order determine the mechanical competence of the femurs the stiffness of both intact and fractured femurs was
measured. Wildtype (n = 8), Lrp52/2 (n = 9), Col1a1-Krm2 (n = 7) 6 SD * p,0.05. (B) mCT analysis was performed to measure callus volume (TV),
maximum moment of inertia (Imax) and bone volume fraction (BV/TV). Wildtype (n = 8), Lrp52/2 (n = 7), Col1a1-Krm2 (n = 7) 6 SD. * p,0.05 versus
Krm2 and Lrp5 Expression Affect Fracture Healing
PLOS ONE | www.plosone.org 5 July 2014 | Volume 9 | Issue 7 | e103250
complete bony bridging in the rigidly fixated groups, bridging was
less successful in osteoporotic mice with the poorest results in
Col1a1-Krm2 mice (Table 2).
mCT measurements of the fracture calli revealed that the
geometrical parameters (total callus volume, maximum moment of
inertia) were slightly decreased in the rigidly fixated osteoporotic
mouse strains compared to wildtype controls indicating inferior
callus formation (Fig. 2B). The relative amount of mineralized
tissue in the osteotomy gap (BV/TV) was significantly decreased in
Lrp52/2 mice but not in Col1a1-Krm2 mice indicating that the
Col1a1-Krm2 transgenic callus was small but transformed to
mineralized tissue (Fig. 2B).
Histologically, we found a lot of cartilage near the osteotomy
gap after 10 days, indicating secondary bone formation at this
location. Intramembranous bone formation started near the
periosteum in some distance to the gap (Fig. 2C). The pattern of
tissue distribution was similar in all groups with the more rigid
fixation. The histomorphometric data revealed no differences in
the relative amount of bone and cartilage after 10 days (Fig. 2D).
After 21 days, cartilage and fibrous tissue were decreased in favor
of newly formed bone in all mice. Confirming the mCT data, the
bone fraction was reduced in Lrp52/2 but not in Col1a1-Krm2
mice. The newly formed bone trabeculae in the callus of the
Col1a1-Krm2 transgenic mice appeared crude and less branched
and the osteoblasts covering the bone surfaces displayed an
irregular morphology. These morphological abnormalities were
not observed in Lrp52/2 mice (Fig. 2C).
Fracture healing is more strongly impaired in Col1a1-
Krm2 mice than in Lrp52/2 mice
In the used mouse model, flexible fracture fixation provoked the
formation of a large callus with inferior mechanical competence
indicating delayed bone healing with predominantly endochondral
bone formation [21]. The mechanically induced delay of fracture
healing was also observed in Lrp52/2 and Col1a1-Krm2 mice.
The flexibilization of the fracture fixation reduced the callus
stiffness by about 25% in wildtype as well as in Lrp52/2 mice with
no significant differences between both genotypes, and by 46% in
Col1a1-Krm2 mice (Fig. 3A). The bony bridging of the callus was
poor, particularly in the osteoporotic mice (Table 2). mCT analysis
revealed that total callus volume and maximum moment of inertia
were more than doubled in all flexibly fixated mice compared to
the rigidly fixated groups with no significant differences between
the genotypes (Fig. 3A). However, the mineralized fraction (BV/
TV) of the calli of all genotypes was significantly decreased
compared to the rigidly fixated groups indicating inferior bone
formation under flexible conditions. Being in line with the
mechanical data the reduction of the mineralized tissue fraction
was most pronounced in the Col1a1-Krm2 transgenic mice
(Fig. 3B). The histomorphometrical data confirmed the mCT data
(Fig. 3C, D). The cartilage fraction in the Lrp52/2 calli was
reduced compared to Col1a1-Krm2 and wildtype mice indicating
reduced endochondral bone formation. This suggestion was
supported by a lower expression of collagen type II in the calli
of Lrp52/2 mice compared to Col1a1-Krm2 and wild-type mice
(Fig. 3E). Taken together the results revealed that bone healing
was most compromised in Col1a1-Krm2 mice under mechanically
unstable conditions.
Identification of differentially expressed genes in fracture
calli of Lrp52/2 and Col1a1-Krm2 mice
To identify genes that may be responsible for the observed
greater impairment of healing in Col1a1-Krm2 mice compared to
that in Lrp52/2 mice, we performed microarray analysis of three
independent callus samples from each mouse strain in the semi-
rigidly fixated group. We collected the samples 10 days after
surgery, because endochondral and intramembraneous bone
formation took place and b-catenin-mediated transcription has
been shown to be active at this time point [13]. Gene expression
profiles of Lrp52/2 and Col1a1-Krm2 mice were each compared
to wildtype mice. We obtained 121 differentially expressed gene
products in calli of Lrp52/2 mice and 829 differentially expressed
gene products in Col1a1-Krm2 mice (Fig. 4A, Table S1). Some of
the gene expression changes were identical in both datasets and
the overlap comprised 39 gene products with increased expression
and 27 gene products with reduced expression (including
osteoblast associated genes Alpl and Pthr1) in both, Col1a1-
Krm2 and Lrp52/2 calli. We focused on differentially expressed
genes associated with bone/ossification and cartilage, to identify
possible candidate genes for the decreased fracture healing
potential we observed (Table 3).
We observed a markedly decreased expression of genes involved
in chondrocyte and/or osteoblast differentiation as well as
endochondral and intramembranous ossification, including Egfr
[23], Fgfr2 [24], Mmp2 [25], Mmp14 [26] and Cd276 [27] in
calli of Col1a1-Krm2 mice, but not in Lrp52/2 mice. According
to the results of the microarray hybridization, osteoblast marker
Col1a2 was significantly decreased in calli of Krm2 over-
expressing mice compared to wildtype. Another marker for
osteoblastogenesis, Alpl was decreased in calli of Col1a1-Krm2
transgenic and Lrp52/2 mice, whereas the microarray results did
not reveal any reliable differences of other well-established
osteoblast differentiation markers, such as Runx2, Col1a1, Bglap
or Spp1.
We did not observe any alterations in the expression of
Tnfrsf11b, which encodes for the RANKL antagonist osteopro-
tegerin that functions as an osteoclastogenesis inhibitor. The gene
has been demonstrated to be regulated by canonical Wnt signaling
[28] and was shown to be significantly reduced in primary
osteoblasts of Col1a1-Krm2 transgenic mice [6].
Furthermore, our microarray data of Col1a1-Krm2 calli
indicated a significant decrease of Phex [29] and Smpd3 [30]
(Table 3), genes described as down-regulated in primary osteo-
blasts of this mouse strain [6]. The decreased expression of Smpd3
is in line with the reduced immunohistological staining of Smpd3
protein that we found in Col1a1-Krm2 transgenic calli (Fig. 5C).
In wildtype mice, Smpd3 was mainly present in osteoblasts in the
peripheral callus and to a less extend in chondroblasts and
precursor cells in the immature tissue in the osteotomy gap.
Staining intensity and pattern was similar in Lrp52/2 calli. The
sphingomyelinase Smpd3 and the product of its enzymatic action
on sphingomyelin, ceramide, are inhibitory factors of bone
resorption [31].
Increased expression of Ctse that encode for cathepsin E,
respectively, indicates enhanced osteoclast activity or number in
Col1a1-Krm2 mice in comparison with wildtype mice [32]. Since
it has been shown that canonical Wnt signaling affects bone
wildtype. (C) For histological analysis, the paraffin sections of the calli were stained with Giemsa at day 10 post fracture. Sections of methacrylate
embedded calli were stained with Paragon at day 21 post fracture. The black arrows indicate crude and less branched bone trabeculae in the callus of
Col1a1-Krm2 mice (D) Histomorphometric evaluation was performed to quantify total osseous tissue, cartilage, and fibrous tissue in the callus at day
10 and 21 post fracture. Wildtype (n = 8), Lrp52/2 (n = 5), Col1a1-Krm2 (n = 5) 6 SD. * p,0.05 versus wildtype.
doi:10.1371/journal.pone.0103250.g002
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resorption, we analyzed osteoclast number in the calli of the three
different genotypes. We found a significantly enhanced number of
TRAP-positive osteoclasts in the peripheral callus of Lrp52/2 as
well as Col1a1-Krm2 mice (Fig. 5A, B).
Only few genes linked to cartilage were differentially expressed
in comparison with wildtype, including Col11a1 that was
decreased in Lrp52/2 mice (Table 3). Decrease of Col11a1
indicates impaired cartilage collagen fibril formation and extra-
cellular matrix formation [33], which may reflect impaired
enchondral bone formation.
It was reported that the only genes whose expression was
decreased in bone of Lrp52/2 mice were the regulators of cell
proliferation CylcinD1, D2 and E1 [34]. We analyzed two of those
genes by qPCR and did not detect differential expression in calli of
Lrp52/2 or Col1a1-Krm2 (Fig. 4B), which might be due to the
different origin of the RNA used in our approach.
As b-catenin has been shown to be a key downstream mediator
in canonical Wnt/b-catenin signaling (26), we analyzed the
occurrence of active b-catenin in the calli of the different
genotypes. Unphosphorylated stabilized b-catenin was predomi-
nantly present in osteoblastic cells lining the periosteum and newly
formed trabeculae as well as in prehypertrophic chondrocytes.
Staining intensity was lowest in Col1a1-Krm2 calli (Fig. 5D).
However, Lrp52/2 calli showed also decreased levels of active b-
catenin in comparison with its occurrence in the calli of wild-type
mice.
Discussion
In the present study, we investigated the influence of Lrp5
deficiency and osteoblast-specific overexpression of Krm2 in
fracture healing using Lrp52/2 and Col1a1-Krm2 mice. Our
data indicated that fracture healing was highly impaired in both
mouse genotypes, but that osteoblast-specific Krm2 overexpression
resulted in an even worse healing phenotype than Lrp5 deficiency.
Moreover, our data revealed that the stronger impairment of
healing in Col1a1-Krm2 was associated with decreased expression
of genes mainly involved in osteogenesis.
Although various findings of mouse genetic studies demonstrat-
ed the crucial influence of Wnt signaling on bone mass
maintenance, the precise biological role of the regulatory
molecules in this process has not yet been fully elucidated. Thus,
in particular the biological role of Lrp5 in bone remodeling is
controversially discussed [34,35]. Although a positive role has been
reported for Krm2 on Lrp6-mediated Wnt signaling, which is
presumably facilitated through an interaction with the Wnt
signaling agonists of the R-Spondin (Rspo) family [36], the
antagonistic effect of Krm2 by binding to the Dkk1 receptors on
canonical Wnt signaling has been well described already before
[9].
In the present study on bone regeneration in Lrp52/2 and
Col1a1-Krm2 mice, biomechanical testing of the fracture calli of
the semi-rigidly fixated groups and comparison of the stiffness of
the fractured femur with the stiffness of the respective genotype-
specific intact femur revealed a more impaired healing in Col1a1-
Krm2 mice than in Lrp52/2 mice. This fact was supported by
analysis of bony bridging of the osteotomy gaps, which was poorest
in the Col1a1-Krm2 group. mCT analysis (bone tissue fraction,
maximum of inertia, tissue volume) of the semi-rigidly fixated
groups revealed that the calli of the Col1a1-Krm2 and Lrp52/2
mice comprised a similarly decreased amount of mineralized tissue
fraction, but Col1a1-Krm2 calli seemed to be smaller compared to
the calli of wild-type mice. Moreover, histological assessment of
the fracture calli showed a stronger impairment of bone
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regeneration in Col1a1-Krm2 transgenic mice, as the bone
trabeculae appeared crude and less branched and the osteoblasts
covering the bone surfaces displayed an irregular morphology.
We have previously shown that both external fixators, which
were used in the present study, allowed fracture healing under
controlled rigid and flexible conditions, and that the more flexible
fixation resulted in delayed bone healing compared to the more
Figure 3. Krm2 overexpression in osteoblasts lead to a more strongly impaired healing than Lrp5 deficiency. The fractured femurs of
wildtype, Col1a1-Krm2 and Lrp52/2 mice were stabilized using a flexible fixator in order to induce delayed healing as described in the Material and
Methods section. (A) In order determine the mechanical competence of the femurs the stiffness of the fractured femurs was measured. (B) mCT analysis
was performed to measure callus volume (TV), maximum moment of inertia (Imax) and bone volume fraction (BV/TV). Wildtype (n= 5), Lrp52/2 (n = 4),
Col1a1-Krm2 (n = 7) 6 SD. * p,0.05 versus wildtype. 1 p,0.05 versus rigidly fixated group. (C) For histological analysis, sections of methacrylate
embedded calli were stained with Paragon at day 21 post fracture. (D) Histomorphometric evaluation was performed to quantify total osseous tissue,
cartilage, and fibrous tissue in the calli at day 21 post fracture. Wildtype (n= 5), Lrp52/2 (n = 4), Col1a1-Krm2 (n = 5)6 SD. * p,0.05 versus wildtype. (E)
Representative images of collagen type II expression detected by immunostaining at day 10 post fracture.
doi:10.1371/journal.pone.0103250.g003
Figure 4. Krm2 overexpression in osteoblasts has a stronger effect on gene expression than Lrp5 deficiency. (A) The numbers indicate
the number of gene products with significantly differential expression in calli of Col1a1-Krm2 and Lrp5-/- mice in comparison to WT mice (for gene
names see Table S1). (B) Relative changes in gene expression of osteoblast associated genes and Wnt target genes. QPCR was performed with
samples prepared from callus tissue under semi-rigid fixation 10 days post-fracture. Gene expression in Col1a1-Krm2 mice and Lrp52/2 mice are
expressed as fold change relative to wildtype mice. Wildtype (n = 6), Lrp52/2 (n = 6), Col1a1-Krm2 (n = 5) 6 SD. * p,0.05, ** p,0.01.
doi:10.1371/journal.pone.0103250.g004
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rigid fixation [21]. In the present study the differences in healing
between the two genotypes became particularly evident in mice in
which the more flexible fixation was used. The more flexible
fixation revealed a significantly reduced bone tissue fraction in
Col1a1-Krm2 mice compared to wild-type mice. These results are
consistent with our histological findings regarding the amount of
bone that was significantly more reduced in Col1a1-Krm2 mice
than in Lrp52/2 mice compared to wild-type mice, when using the
more flexible fixation and consistent with the observation that
Col1a1-Krm2 mice exhibited a significantly more severe osteopo-
rotic phenotype than Lrp52/2 mice that has been shown to be due
to increased bone resorption as well as disturbed osteoblast
maturation and bone formation [6,7]. Our data from the flexible
group at day 21 indicated that cartilage tissue was significantly
more increased in Col1a1-Krm2 than in Lrp52/2 mice. We
assume that in Col1a1-Krm2 mice less bone tissue might result, at
least in part, from increased cartilage production and mainly from
reduced intramembranous bone formation. The differentiation of
osteoblast precursor cells into the osteogenic lineage should be
impaired by osteoblast-specific Krm2 overexpression and instead
these cells could convert into chondrogenic cells. These assump-
tions are in line with previous studies demonstrating that in
osteoblast precursors lacking b-catenin osteogenic differentiation is
inhibited and these cells develop into chondrocytes [17].
Ex vivo studies on Col1a1-Krm2 osteoblasts suggested a cell-
autonomous differentiation defect underlying the osteoporotic
phenotype of Col1a1-Krm2 mice and indicated a reduced Wnt3a-
dependent activation of canonical Wnt signaling among other by
decreased total b-catenin levels in Col1a1-Krm2 osteoblasts
compared to wild-type osteoblasts.
The latter finding is in line with the results of the present study
because immunohistological validation of active b-catenin levels in
the callus tissue revealed less active b-catenin in the calli of
Col1a1-Krm2 mice than in calli of wild-type mice. Active b-
catenin was predominantly detected in cells surrounding the
cartilage, in prehypertrophic chondrocytes as well as in osteoblasts
lining the periosteum and the woven bone. Hypertrophic
chondrocytes and osteoblasts, more deeply embedded in the bone
matrix did not reveal significantly active b-catenin staining. The
callus tissue of Lrp52/2 mice revealed a similar staining
distribution to that in wild-type mice. However, in Lrp52/2 mice,
overall active b-catenin staining was lower than in wild-type mice.
These findings are consistent with the results from a former
study on bone regeneration in mice which provided evidence of
active canonical Wnt signaling in intramembranous and endo-
chondral ossification [37] and possibly account for the decreased
intramembranous bone formation in Col1a1-Krm2 and Lrp52/2
mice as well as the significantly diminished endochondral bone
formation that was seen especially in Lrp52/2 mice with the more
flexible fixation in the present study. Cartilage tissue was not
significantly altered in Lrp52/2 mice treated with the more rigid
fixation at day 10 of healing compared to Col1a1-Krm2 and
Table 3. Candidate genes for impaired fracture healing in Col1a1-Krm2 and Lrp52/2 mice.
Microarray
Col1a1-
Krm2
(n = 3)
Lrp52/2
(n =3)
Gene Gene Title Probe set ID FC SD FC SD
Bone/Ossification
Alpl alkaline phosphatase, liver/bone/kidney 1423611_at 0.57 0.24 0.66 0.23
Cd276 CD276 antigen 1417599_at 0.58 0.19 _ _
Col13a1 collagen, type XIII, alpha 1 1422866_at 0.61 0.28 _ _
Col1a2 collagen, type I, alpha 2 1446326_at 0.66 0.27 _ _
Ctse cathepsin E 1418989_at 4.22 2.38 _ _
Egfr epidermal growth factor receptor 1435888_at 0.62 0.17 _ _
Fgfr2 fibroblast growth factor receptor 2 1433489_s_at 0.61 0.26 _ _
Lrrc17 leucine rich repeat containing 17 1429679_at 0.62 0.15 _ _
Mmp14 matrix metallopeptidase 14 1416572_at 0.54 0.21 _ _
Mmp2 matrix metallopeptidase 2 1439364_a_at 0.63 0.25 _ _
Pbx1 pre B-cell leukemia transcription factor 1 1440037_at 1.91 0.59 _ _
Phex phosphate regulating gene with homologies to endopeptidases on the X chromosome 1421979_at 0.71 0.24 _ _
Pth1r parathyroid hormone 1 receptor 1417092_at 0.60 0.39 0.66 0.33
Smpd3 sphingomyelin phosphodiesterase 3, neutral 1422779_at 0.52 0.18 _ _
Tgfb2 transforming growth factor, beta 2 1450923_at 0.56 0.26 _ _
Cartilage
Aspn asporin 1416652_at 0.55 0.16 _ _
Col11a1 collagen, type XI, alpha 1 1449154_at _ _ 0.77 0.23
Differential gene expression in callus tissue was analyzed 10 days post-fracture by microarray analysis (n = 3). Only gene products that fulfilled criteria for significant
gene expression changes (see methods) are listed.
FC: mean value of fold changes of the cross-wise comparisons with wildtype callus (n = 3) as determined by microarray analysis.
SD: standard deviation.
_ no significantly differential expression when compared to wildtype callus (n = 3) as determined by microarray analysis.
doi:10.1371/journal.pone.0103250.t003
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wildtype mice. However, in Lrp52/2 mice with the flexible
fixation cartilage tissue at day 21 was signficantly decreased
compared to Col1a1-Krm2 as well as to wildtype mice. This result
suggests that Lrp5 deficiency did not result in increased or
prolonged cartilage production compared to Col1a1-Krm2 and
wildtype mice. Reduced bone tissue in these mice seemed to be
due to decreased endochondral as well as intramembranous bone
formation. This is in line with previous studies demonstrating that
mice conditionally expressing b-catenin null alleles had a lack of
bone as well as cartilage and showed immature mesenchymal cells
persisting at the fracture sites [13]. Mesenchymal cells that begin
to show phenotypic features of either chondrocyte or osteoblast
precursors exhibit b-catenin mediated transcription [13]. Thus,
Lrp52/2 mice that are characterized by mesenchymal stem cells
with less b-catenin signaling due to Lrp5 deficiency showed less
chondogenic as well as osteogenic tissue with the flexible fixation
in the present study. We detected less staining of collagen type II in
prechondrogenic mesenchymal stem cells and chondogenic cells in
the calli of Lrp52/2 mice compared to Col1a1-Krm2 and wildtype
mice. The latter finding together with the altered staining for
active b-catenin detected in the calli of Lrp52/2 mice suggests an
important role for Lrp5 as Wnt-coreceptor in endochondral bone
formation.
It has been shown that Kremen proteins decrease Wnt/b-
catenin signaling by binding to Dkk1 [9] and that Tnfrsf11b, the
gene encoding the osteoclast-inhibitory factor Opg, being known
to be induced by canonical Wnt signaling in osteoblasts [28], is
downregulated in Col1a1-Krm2 mice [6], explaining the increased
bone resorption and osteolytic lesions in the lower extremities in
these mice. In contrast, bone resorption seemed to be unaffected in
Lrp52/2 mice [7] and studies on mice expressing a mutant Lrp5
gene associated with high bone mass (HBM) demonstrated no
significant changes in osteoclast number and function [4],
suggesting that Lrp5 is not directly involved in regulating
osteoclastogenesis and osteoclast activity. However, a more recent
study showed an increase of the osteoclast surface in mice with a
lack in Lrp5, implying that bone resorption might be affected by
Lrp5 deficiency [38]. This would be consistent with our findings,
which did not only reveal the expected significantly increased
osteoclast number in the calli of Col1a1-Krm2 mice, but also in
the calli of Lrp52/2 mice, as assessed by histochemical staining of
TRAP positive cells. In line with the results of Schulze et al. [6]
regarding the expression of the sphingomyelinase Smpd3, that has
been identified as an inhibitory factor of bone resorption [31] and
has been shown to be downregulated in Col1a1-Krm2 osteoblasts
[6], we detected less expression of Smpd3 in the calli of Col1a1-
Krm2 mice as verified by immunohistochemistry and microarray
expression analysis. However, Smpd3 expression did not seem to
be decreased in the calli of Lrp52/2 mice. Nevertheless, the altered
staining for active b-catenin in the fracture calli of Lrp52/2 mice
suggests that Lrp5 acts on canonical Wnt signaling in osteoblasts,
which is compatible with the finding of a systemic influence of
Figure 5. Krm2 overexpression and Lrp5 deficiency result in increased osteoclast number. (A) Osteoclasts were identified by histochemical
staining of tartrat-resistant acid phosphatase (TRAP) at day 10 post fracture. (B) Osteoclast number was determined in the peripheral callus at day 10
post fracture. Wildtype (n = 6), Lrp52/2 (n = 4), Col1a1-Krm2 (n = 5) 6 SD. * p,0.05 versus wildtype. Representative images of (C) Smpd3 expression
and (D) active b-catenin levels detected by immunostaining at day 10 post fracture.
doi:10.1371/journal.pone.0103250.g005
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Lrp5 on bone formation. Interestingly, patients suffering from a
non-classical form of osteopetrosis, the autosomal dominant
osteopetrosis type I (ADOI), which is caused by a specific gain-
of-function mutation in the LRP5 gene and is associated with a
high bone mass phenotype, have abnormally low number of
osteoclasts in vivo [39]. Results from later studies on osteoclasts
from theses patients strongly suggested that the specific ADOI
phenotype is caused by the reduced ability of osteoblasts to support
osteoclast development due to increased b-catenin-dependent Opg
expression [40], implying that Lrp5 might regulate canonical Wnt
signaling and indirectly osteoclast differentiation by modulation
Opg expression.
Skeletal defects in mice caused by Lrp5 loss-of-function
mutations manifest primarily during the postnatal period [7],
whereas Lrp6-deficient mice are not viable, underlining the
particular role of Lrp6 in embryogenesis [41]. However, it has
already been shown that Lrp5 and Lrp6 exert overlapping
functions in the control of postnatal bone mass accrual [42–44],
and since Lrp5 and Lrp6 are highly homologous and are
coexpressed in primary osteoblasts it can be assumed that Lrp6
is able to compensate for Lrp5 function during some stages of
osteoblast differentiation [35]. This compensation might be the
reason for the less impaired healing that was observed in Lrp52/2
mice compared to Col1a1-Krm2 mice in our study. Since Krm2 is
acting by binding to Dkk1 that can inhibit Wnt signaling through a
direct interaction with both, Lrp5 and Lrp6, a poorer healing in
Col1a1-Krm2 mice might be expected due to a more pronounced
decrease of bone formation and increased bone resorption in these
mice. To address this hypothesis we performed microarray
analysis, using RNA from calli of each mouse genotype to identify
genes that might be responsible for the observed differences in
healing in the two genotypes. In the calli of both mouse genotypes
we observed a significantly decreased expression of genes
associated with osteogenesis, including Alpl and Col1a2, however,
more ossification-related genes showed decreased expression in the
calli of Col1a1-Krm2 mice. Moreover, expression of the gene,
encoding the gastric aspartyl protease cathepsin E (Ctse) that has
also been found to be expressed in active osteoclasts [32], was
significantly upregulated only in the calli of Col1a1-Krm2 mice, an
observation that is in line with our finding of enhanced osteoclast
number in Col1a1-Krm2 mice. The latter finding and the reduced
expression of more osteogenesis-associated genes might at least be
in part responsible for the more impaired bone healing observed in
Col1a1-Krm2 mice compared to Lrp52/2 mice.
In conclusion, our data underscore the important role of
canonical Wnt signaling in bone formation as well as in drug
targeting approaches, both in low bone mass diseases and in
impaired fracture healing. Moreover, our data confirmed that
activation of canonical b-catenin signaling as a therapy for fracture
healing improvement should be restricted to mesenchymal
precursor cells already committed to the osteogenic lineage. Since
Krm2 plays a crucial role in regulating bone formation,
antagonizing KRM2 during a defined time of fracture healing
might be an interesting option to improve fracture healing under
compromised conditions, such as osteoporosis.
Supporting Information
Table S1 Differentially expressed gene products in
fracture calli of Col1a1-Krm2 and Lrp52/2 mice. Differ-
ential gene expression in callus tissue under semi-rigid fixation was
analyzed 10 days post-fracture by microarray analysis (n = 3
each). Only gene products that fulfilled criteria for significant gene
expression changes (see methods) are listed. FC: mean value of fold
changes of the cross-wise comparisons with wildtype callus. SD:
standard deviation. _ no significantly differential expression when
compared to wildtype callus.
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